Foley Hoag advised Daewoong Pharmaceutical on the deal. South Korea’s Daewoong Pharmaceutical (“Daewoong”) secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based multinational company focused...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Applied Genetic Technologies Corporation (“AGTC”) on the deal. Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC”), a clinical-stage biotechnology company focused on the development...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Hosta.ai on the deal. New artificial intelligence property technology company Hosta.ai (“Hosta”) announced an $11.5 million Series A financing led by Eclipse Ventures, with participation...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised H.I.G. BioHealth Partners and Accelmed Partners on the deal. H.I.G. BioHealth Partners and Accelmed Partners acted as new investors and co-leads in the...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised HiFiBiO Therapeutics on the deal. FibroGen, Inc. (Nasdaq: FGEN) and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune...
You must be a Standard 1 Year member to access this content.
